FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to cardiology, and can be used in predicting the risk of nonarrhythmic death in patients with heart failure and an implanted cardioverter-defibrillator. Patient’s social position is assessed - working or not working, level of systolic pressure in pulmonary artery according to echocardiography, history of chronic obstructive pulmonary disease, drug therapy of heart failure and beta-blockers. Based on the obtained data, the probability (P) of developing nonarrhythmic death is calculated by a given formula. If the P value is more than 20 %, a high risk of developing nonarrhythmic death is predicted in the four-year follow-up period.
EFFECT: method enables to identify those patients in whom the implantation of the cardioverter-defibrillator is not able to significantly improve the remote prognosis due to a high risk of nonarrhythmic death, and, as a result, reduce the risk of unreasonable intervention by assessing the set of the most significant indicators.
1 cl, 1 dwg, 3 tbl, 2 ex
Authors
Dates
2024-06-11—Published
2023-05-03—Filed